Internet publication
Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- Abstract:
-
Background: Molnupiravir and nirmatrelvir-ritonavir (Paxlovid) are oral antivirals that have been proposed as treatments for patients admitted to hospital with COVID-19.
Methods: In this randomised, controlled, open-label, adaptive platform trial, several potential treatments for patients hospitalised with COVID-19 pneumonia were evaluated. Molnupiravir and nirmatrelvir-ritonavir were assessed in separate comparisons in RECOVERY, both of whic...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Not peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Pre-print, pdf, 565.0KB, Terms of use)
-
- Publisher copy:
- 10.1101/2024.05.23.24307731
Authors
- Host title:
- medRxiv
- Publication date:
- 2024-05-24
- DOI:
- Language:
-
English
- Keywords:
- Pubs id:
-
2002515
- Local pid:
-
pubs:2002515
- Deposit date:
-
2024-06-25
- ARK identifier:
Terms of use
- Copyright holder:
- Horby et al.
- Copyright date:
- 2024
- Rights statement:
- © 2024 The Author(s). The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record